Fulgent Genetics


ATLANTA, GA – – (Newsfile Corp. – September 20, 2022) – – Holzer & Holzer, LLC informs investors that a class action lawsuit was filed against Fulgent Genetics, Inc. (“Fulgent Genetics” or the “Company”) (NASDAQ: FLGT).  The lawsuit alleges Fulgent Genetics made materially false and misleading statements and/or failed to disclose material adverse facts about its business, operations, and compliance policies, including: (1) Fulgent Genetics had been conducting unnecessary laboratory testing, engaging in improper billing practices, and providing or receiving remuneration in violation of the Anti-Kickback Statute and Stark Law; (2) accordingly, the Company was likely to become subject to enhanced legal and regulatory scrutiny; (3) the Company’s revenues, to the extent they were derived from the unlawful conduct, were unsustainable; and (4) the foregoing, once revealed, was likely to subject Fulgent Genetics to significant financial and/or reputational harm.


If you bought shares of Fulgent Genetics between March 22, 2019 and August 4, 2022, and you suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey Holzer, Esq. at cholzer@holzerlaw.com or Joshua Karr, Esq. at jkarr@holzerlaw.com, by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at https://holzerlaw.com/case/fulgent-genetics/ to learn more.


The deadline to ask the court to be appointed lead plaintiff in the case is November 21, 2022.

Registration Deadline

Lead Plaintiff Deadline Has Passed

November 21, 2022

Submit Your Information

Shares Purchased
Date Puchased
Number of Shares Acquired
Acquisition Price Per Share
Shares Sold
Date Sold
Number of Shares Sold
Selling Price Per Share
By clicking on the button below, I am requesting Holzer & Holzer, LLC send me documents necessary to retain the firm.